Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.
about
Optimization therapy for the treatment of chronic hepatitis BShort-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.Correlation of hepatitis B surface antigen level with response to telbivudine in naive patients with chronic hepatitis B.Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B.
P2860
Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@ast
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@en
type
label
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@ast
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@en
prefLabel
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@ast
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@en
P2093
P2860
P1476
Pretreatment serum HBsAg-to-HB ...... ecavir in chronic hepatitis B.
@en
P2093
Bo Young Min
Cheol Min Shin
Dong Ho Lee
Jin Hyeok Hwang
Jin Wook Kim
Jong Yeop Kim
Joon Chang Song
Sang Hyub Lee
Sook Hyang Jeong
Yeo Myeong Kim
P2860
P304
P356
10.3350/KJHEP.2011.17.4.268
P50
P577
2011-12-01T00:00:00Z